Perceptive Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-152,714
| Closed | -$417K | – | 115 |
|
|
2025
Q4 | $417K | Buy |
+152,714
| New | +$353K | 0.01% | 113 |
|
|
2025
Q2 | – | Sell |
-12,711,788
| Closed | -$42.3M | – | 97 |
|
|
2025
Q1 | $42.3M | Sell |
12,711,788
-9,400,478
| -43% | -$48.5M | 1.5% | 17 |
|
|
2024
Q4 | $164M | Sell |
22,112,266
-4,505,443
| -17% | -$41.8M | 4.56% | 6 |
|
|
2024
Q3 | $250M | Buy |
26,617,709
+684,567
| +3% | +$6.49M | 5.36% | 4 |
|
|
2024
Q2 | $208M | Buy |
25,933,142
+6,660,151
| +35% | +$71.4M | 5.02% | 4 |
|
|
2024
Q1 | $286M | Buy |
19,272,991
+7,293,576
| +61% | +$84.9M | 5.03% | 3 |
|
|
2023
Q4 | $97.4M | Buy |
11,979,415
+16,477
| +0.1% | +$86.2K | 2.18% | 10 |
|
|
2023
Q3 | $54.4M | Sell |
11,962,938
-2,073,472
| -15% | -$13.5M | 1.83% | 16 |
|
|
2023
Q2 | $98.8M | Sell |
14,036,410
-1,303,325
| -8% | -$9.33M | 2.87% | 6 |
|
|
2023
Q1 | $93.7M | Buy |
15,339,735
+5,367,955
| +54% | +$37M | 2.77% | 10 |
|
|
2022
Q4 | $63.7M | Sell |
9,971,780
-276,844
| -3% | -$2.16M | 1.84% | 20 |
|
|
2022
Q3 | $98.2M | Sell |
10,248,624
-1,577,675
| -13% | -$18.2M | 2.85% | 11 |
|
|
2022
Q2 | $131M | Sell |
11,826,299
-374,962
| -3% | -$4.91M | 4.1% | 5 |
|
|
2022
Q1 | $203M | Buy |
12,201,261
+2,073,320
| +20% | +$32.1M | 4.07% | 5 |
|
|
2021
Q4 | $193M | Sell |
10,127,941
-1,361,831
| -12% | -$30M | 2.99% | 6 |
|
|
2021
Q3 | $283M | Buy |
11,489,772
+530,000
| +5% | +$12.5M | 4.13% | 5 |
|
|
2021
Q2 | $285M | Buy |
10,959,772
+2,307,987
| +27% | +$60M | 3.71% | 5 |
|
|
2021
Q1 | $274M | Sell |
8,651,785
-514,519
| -6% | -$21.3M | 3.64% | 5 |
|
|
2020
Q4 | $425M | Sell |
9,166,304
-919,328
| -9% | -$36.5M | 4.58% | 5 |
|
|
2020
Q3 | $332M | Sell |
10,085,632
-1,723,862
| -15% | -$52.8M | 4.89% | 4 |
|
|
2020
Q2 | $324M | Buy |
11,809,494
+139,437
| +1% | +$4.58M | 5.26% | 4 |
|
|
2020
Q1 | $349M | Buy |
11,670,057
+2,253,855
| +24% | +$59.7M | 9.1% | 1 |
|
|
2019
Q4 | $261M | Sell |
9,416,202
-1,598,500
| -15% | -$36.4M | 5.21% | 5 |
|
|
2019
Q3 | $200M | Sell |
11,014,702
-900,425
| -8% | -$19.9M | 5.41% | 4 |
|
|
2019
Q2 | $292M | Sell |
11,915,127
-320,684
| -3% | -$4.83M | 6.7% | 4 |
|
|
2019
Q1 | $116M | Sell |
12,235,811
-5,300
| -0% | -$51.5K | 3.29% | 7 |
|
|
2018
Q4 | $108M | Buy |
12,241,111
+4,950,912
| +68% | +$47.7M | 4.12% | 5 |
|
|
2018
Q3 | $82M | Buy |
7,290,199
+1,437,997
| +25% | +$20.4M | 2.2% | 9 |
|
|
2018
Q2 | $74.9M | Sell |
5,852,202
-310,000
| -5% | -$4.53M | 1.96% | 10 |
|
|
2018
Q1 | $104M | Buy |
6,162,202
+1,386,088
| +29% | +$21M | 2.93% | 7 |
|
|
2017
Q4 | $38.2M | Buy |
4,776,114
+50,000
| +1% | +$401K | 1.27% | 19 |
|
|
2017
Q3 | $36.6M | Buy |
4,726,114
+363,000
| +8% | +$2.3M | 1.4% | 15 |
|
|
2017
Q2 | $32.1M | Buy |
4,363,114
+795,561
| +22% | +$5.06M | 1.66% | 16 |
|
|
2017
Q1 | $26.6M | Hold |
3,567,553
| – | – | 1.52% | 19 |
|
|
2016
Q4 | $24.8M | Hold |
3,567,553
| – | – | 1.77% | 13 |
|
|
2016
Q3 | $29.4M | Sell |
3,567,553
-44,423
| -1% | -$376K | 1.91% | 11 |
|
|
2016
Q2 | $29.3M | Buy |
3,611,976
+824,720
| +30% | +$5.18M | 2.38% | 11 |
|
|
2016
Q1 | $14.2M | Sell |
2,787,256
-212,905
| -7% | -$1.17M | 1.28% | 19 |
|
|
2015
Q4 | $23.2M | Buy |
3,000,161
+44,705
| +2% | +$310K | 1.79% | 15 |
|
|
2015
Q3 | $17M | Buy |
2,955,456
+195,863
| +7% | +$1.53M | 1.55% | 19 |
|
|
2015
Q2 | $25.3M | Buy |
2,759,593
+45,044
| +2% | +$503K | 1.65% | 13 |
|
|
2015
Q1 | $32.9M | Buy |
+2,714,549
| New | +$30.6M | 2.64% | 6 |
|
Other funds holding IOVA
MFM
VCM
VPM
ICM